Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02917928Phase 2Unknown
Phase 2, randomised, double-blind trial (2 arms), sponsored by Monash University. Primary endpoint: Change in Oral Glucose Tolerance Test at 14 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02917928.